who should not use glp 1 patches The Truth About GLP-1 Patches: Do They Actually Work? GLP-1 Patches: Do They Actually
Description
,
In this trial, at 60 weeks, the exenatide group showed a significant improvement in MDS-UPDRS Part III scores compared to the placebo group among the 62 recruited patients (80)
GLP-1 receptor agonists like semaglutide and tirzepatide are linked to significantly lower risks of dementia, ischemic stroke, and all-cause mortality in adults with type 2 diabetes and obesity, according to a large US cohort study
They showed better effects in improving mouse motor function scores, promoting the repair and regeneration of synapses or dopaminergic neurons (TH+, GDNF, synaptophysin), and inhibiting neuroinflammatory responses (IBA-1, IL-2) compared to liraglutide and DA-JC1, highlighting the advantage of targeting more sites
( PMID: 15767025 ) Wang JY, French LE, Shear NH, Amiri A, Alavi A (2018) Drug-induced pyoderma gangrenosum: a review
Many patients start by injecting GLP-1 in areas such as the abdomen, thigh, or upper arm
